The retrospective findings could prompt a clinical trial, but for now, physicians should feel free to choose either denosumab or a bisphosphonate.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/hypercalcemia-malignancy-what-osteoporosis-drug-best-2025a1000og9?src=rss
Author :
Publish date : 2025-09-16 12:11:00
Copyright for syndicated content belongs to the linked Source.
